ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
Bristol-Myers Slides After Another Lung Cancer Drug Setback
Article By: The Fly
Friday, January 20, 2017 12:07 PM EST
Shares of Bristol-Myers Squibb are sliding after the company announced that it will not pursue an accelerated regulatory path for the Opdivo/Yervoy combination, with research firm Cowen downgrading the stock to Market Perform following the news.
In this article: BMY Also: MRK, AZN, RHHBY
Read
Analysts See Merck Rally Continuing After Lung Cancer Drug News
Article By: The Fly
Thursday, January 12, 2017 2:31 PM EST
After the FDA granted priority review status to Merck's Keytruda drug, a number of analysts expressed optimism about the company's outlook in notes to investors today.
In this article: MRK Also: BMY, AZN, RHHBY
Read
Bristol-Myers Slips After FDA Gives Merck Lung Cancer Therapy Priority Review
Article By: The Fly
Wednesday, January 11, 2017 11:50 AM EST
Shares of Merck are on the rise after the company announced the Food and Drug Administration has accepted for priority review its application for its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer.
In this article: MRK Also: BMY, AZN, RHHBY
Read
NewLink Pops After Incyte And Merck Announce IDO Inhibitor Pact
Article By: The Fly
Monday, January 9, 2017 2:37 PM EST
Shares of NewLink Genetics, a developer of immunotherapeutic products to enhance treatment options for patients with cancer, are exploding to the upside after peer Incyte announced a collaboration with Merck.
In this article: NLNK Also: INCY, MRK, RHHBY
Read
Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year
Article By: The Fly
Monday, December 19, 2016 12:48 PM EST
Shares of Merck are sliding after Jefferies analyst Jeffrey Holford downgraded the stock to Underperform.
In this article: MRK, BMY, BAYRY Also: AZN, RHHBY, MON, ABBV, LLY, NVS, SNY, NVO, PFE, JNJ
Read

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!